ELAM SAFI: Open Payments
NPI 1780646141 · WARE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 11 payments from 5 companies in 2025. Trend: 2023 $43 · 2024 $119 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, GEMTESA.
Industry payments across MA — which companies pay providers there.
